UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Boosts Stock Position in The Cooper Companies, Inc. $COO

Key Points

• UBS Asset Management increased its stake in The Cooper Companies by 15.5%, owning over 2.1 million shares valued at approximately $179 million as of the last quarter.
• CEO Albert G. White III purchased 10,000 shares at an average cost of $68.39, raising his ownership to 226,151 shares, valued at approximately $15.47 million.
• Cooper Companies reported a quarterly earnings of $1.10 per share, exceeding expectations, with revenue of $1.06 billion indicating a year-over-year growth of 5.7%.

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 15.5% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,121,835 shares of the medical device company's stock after purchasing an additional 284,943 shares during the quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned 1.06% of Cooper Companies worth $178,977,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the stock. Shell Asset Management Co. lifted its position in Cooper Companies by 15.5% in the fourth quarter. Shell Asset Management Co. now owns 946 shares of the medical device company's stock worth $87,000 after buying an additional 127 shares during the last quarter. UMB Bank n.a. lifted its position in Cooper Companies by 16.7% in the first quarter. UMB Bank n.a. now owns 902 shares of the medical device company's stock worth $76,000 after buying an additional 129 shares during the last quarter. Horizon Investments LLC lifted its position in Cooper Companies by 5.0% in the first quarter. Horizon Investments LLC now owns 2,859 shares of the medical device company's stock worth $241,000 after buying an additional 136 shares during the last quarter. Axxcess Wealth Management LLC lifted its position in Cooper Companies by 1.9% in the first quarter. Axxcess Wealth Management LLC now owns 7,382 shares of the medical device company's stock worth $623,000 after buying an additional 140 shares during the last quarter. Finally, Mitchell & Pahl Private Wealth LLC lifted its position in Cooper Companies by 1.8% in the first quarter. Mitchell & Pahl Private Wealth LLC now owns 8,675 shares of the medical device company's stock worth $732,000 after buying an additional 157 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, CEO Albert G. White III acquired 10,000 shares of the stock in a transaction that occurred on Friday, September 5th. The stock was bought at an average cost of $68.39 per share, with a total value of $683,900.00. Following the completion of the purchase, the chief executive officer directly owned 226,151 shares in the company, valued at $15,466,466.89. The trade was a 4.63% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Brian G. Andrews acquired 1,525 shares of the stock in a transaction that occurred on Tuesday, September 2nd. The stock was acquired at an average cost of $65.68 per share, with a total value of $100,162.00. Following the completion of the purchase, the executive vice president owned 22,191 shares of the company's stock, valued at $1,457,504.88. This trade represents a 7.38% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased 15,975 shares of company stock valued at $1,079,566 in the last ninety days. 1.98% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on COO. BNP Paribas Exane upgraded Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price target for the company in a research report on Tuesday, July 22nd. UBS Group upgraded Cooper Companies to a "buy" rating in a research report on Tuesday, June 17th. Wall Street Zen lowered shares of Cooper Companies from a "buy" rating to a "hold" rating in a research note on Saturday, July 12th. Piper Sandler lowered their target price on shares of Cooper Companies from $105.00 to $83.00 and set an "overweight" rating for the company in a research note on Thursday, August 28th. Finally, JPMorgan Chase & Co. lowered their target price on shares of Cooper Companies from $76.00 to $66.00 and set a "neutral" rating for the company in a research note on Thursday, August 28th. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, Cooper Companies presently has an average rating of "Moderate Buy" and a consensus price target of $86.64.

Cooper Companies Stock Up 1.2%

Shares of COO opened at $68.46 on Friday. The Cooper Companies, Inc. has a 12-month low of $61.78 and a 12-month high of $112.38. The firm has a fifty day moving average price of $71.66 and a 200-day moving average price of $76.16. The firm has a market capitalization of $13.61 billion, a P/E ratio of 33.72, a P/E/G ratio of 1.78 and a beta of 0.97. The company has a current ratio of 2.12, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, topping analysts' consensus estimates of $1.07 by $0.03. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The company had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.06 billion. During the same period in the prior year, the firm earned $0.96 earnings per share. The firm's revenue for the quarter was up 5.7% compared to the same quarter last year. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Equities research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.